Cancer Cell International投稿须知

期刊简介

《Cancer Cell International》是由BioMed Central出版社于2001年创办的英文国际期刊（ISSN: 1475-2867，E-ISSN: 1475-2867），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为ONCOLOGY。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA开放获取模式（OA占比1%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比73.89%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在314篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Cell International审稿周期约为约1月。该刊近年被列入国际预警名单，年发文量约314篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
是是否预警
SCIE 期刊收录
314 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	ONCOLOGY 肿瘤学 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	ONCOLOGY 肿瘤学 3区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	61 / 322	81.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	65 / 322	79.97%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：10.9

SJR：1.257

SNIP：0.92

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Genetics	Q1	37 / 347	89%
大类：Biochemistry, Genetics and Molecular Biology 小类：Oncology	Q1	52 / 404	87%
大类：Biochemistry, Genetics and Molecular Biology 小类：Cancer Research	Q1	45 / 230	80%

期刊发文

Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages
Author: Dong, Hui; Li, Mengli; Yang, Chen; Wei, Wei; He, Xianglei; Cheng, Gang; Wang, Shibing

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-022-02846-x
Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis
Author: Zhang, Kai; Wu, Yue; Chen, Guangliang; Wang, Hao; Liu, Yongsheng; Zhou, Youxin

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02848-3
Long noncoding RNAs: glycolysis regulators in gynaecologic cancers
Author: Lv, Nengyuan; Shen, Siyi; Chen, Qianying; Tong, Jinyi

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02849-2
RGS proteins and their roles in cancer: friend or foe?
Author: Li, Lin; Xu, Qiang; Tang, Chao

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02932-8
LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis
Author: Huang, Jiang; Yang, Yunfang; Zhao, Fulan; Zhang, Zhuo; Deng, Jian; Lu, Wei; Jiang, Xian

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02901-1
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer
Author: Wang, Fukai; Ma, Shuangshuang; Chen, Panpan; Han, Yuhao; Liu, Zhaoyun; Wang, Xinzhao; Sun, Chenglong; Yu, Zhiyong

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02908-8
Aspirin increases chemosensitivity of colorectal cancer cells and inhibits the expression of toll-like receptor 4
Author: Ying, Jun; Zhou, Haiyang; Wang, Zhiguo; You, Qing; Chen, Junnan; Lu, Hao; Zhang, Jian

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-023-02847-4
Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma
Author: Li, Jian; Yin, Jingyang; Li, Wenhua; Wang, Huaizhi; Ni, Bing

Journal: CANCER CELL INTERNATIONAL. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12935-022-02836-z

Cancer Cell International

国际癌细胞

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询